BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

EyeGate Pharma 

100 Beaver Street

Waltham  Massachusetts  02453-8425  U.S.A.
Phone: 781-788-8869 Fax:


SEARCH JOBS




Industry
Medical Device






 Company News
EyeGate Pharma's EGP-437 Matches the Standard-of-Care's Response Rate in Phase III Study in Patients With Anterior Uveitis 4/9/2013 11:40:38 AM    More...
EyeGate Pharma Enrolls Last Patient in Pivotal Phase III Anterior Uveitis Study of EGP-437 12/18/2012 8:45:33 AM    More...
EyeGate Pharma Initiates Phase III Study of EGP-437 in Patients With Anterior Uveitis 1/5/2012 9:06:00 AM    More...
EyeGate Pharma Secures Additional $5.9M Series D Venture Funding 1/5/2011 6:42:21 AM    More...
EyeGate Pharma Awarded Grants Totaling Nearly $1 Million by United States Government Section 48D Therapeutic Discovery Program 11/4/2010 9:15:13 AM    More...
RXi Pharmaceuticals (RXII) and EyeGate Pharma Announce Collaboration Focused on Non-Invasive Ocular Delivery of RNAi Therapeutics 9/22/2010 9:56:16 AM    More...
EyeGate Pharma Initiates ALLUVION Phase III Study of EGP-437 in Patients With Dry Eye Syndrome 6/24/2010 8:41:15 AM    More...
EyeGate Pharma Establishes Research Collaboration With GlaxoSmithKline (GSK) to Deliver Medicines Using the EyeGate(R) II Delivery System 4/29/2010 11:20:47 AM    More...
EyeGate Pharma Completes Phase II Study of EGP-437 in Patients With Anterior Uveitis 3/25/2010 11:04:58 AM    More...
EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrome 1/8/2010 7:05:10 AM    More...
1234